Cancer drugs
Tel Aviv University study reveals how tumors hijack immune cells to fuel cancer growth and spread
The research focused on macrophages, immune cells responsible for removing damaged and dead cells from the body.
Israeli-founded AI biotech Immunai launches drug-discovery collaboration with Boehringer Ingelheim
New shot for cancer can eradicate whole tumors in patients, trial shows - report
Late-stage trial finds a new pill extends survival for people with pancreatic cancer
Innovative new drug could be key to combatting childhood brain tumors - study
Mixing these two cancer drugs could be the answer to childhood brain cancer treatment.
Israeli, Spanish researchers create an 'Iron Dome' for cancer - study
Raise the efficacy of cancer nanotherapies with remote-controlled delivery of chemo drugs at precise release rates.
L’maanchem holds medical innovation conference in Tel Aviv
The keynote speaker at the conference was Prof. Eugen B. Hug, a world-renowned expert and one of the developers of proton radiation innovative treatment.
This drug could stop Ashkenazi women from developing breast cancer
Dr. Larisa Ryvo now works with Olaparib to prevent breast cancer from occurring or recurring.
Can vegetables help treat cancer? - study
Compounds found in some types of nightshade plants long used in traditional medicine could aid in the development of new cancer therapies.
Israeli firm NeoTX tries to treat cancer by 'tricking' immune system
Three Nobel Prize winners and an immigrant to Israel ‘trick’ the immune system to fight the disease known as cancer on its own.
Israel nanotech breakthrough automatically targets tumors with anti-cancer drugs
An automated process creating robot-chemists and robot-pharmacists makes nanocapsules that send anti-cancer drugs directly to malignancies.
Meet the company poised to transform the cancer therapy landscape
Enlivex's Shai Novik will present at the Jerusalem Post Annual Conference on Sept. 12
Special drug class could be used to reverse damage from radiotherapy - study
By testing senolytic drugs on mice, researchers found that those treated shortly after radiotherapy did not suffer from premature aging.
The future of personalized medicine is already in Israel
Progenetics, founded by Manaster in 2015, bridges the gap between standard medicine and the cutting-edge oncological diagnostic services available today.
